Advanced Health Intelligence Ltd (MYZQF)
- Previous Close
0.0000 - Open
0.0050 - Bid 0.0040 x --
- Ask 0.2000 x --
- Day's Range
0.0050 - 0.0050 - 52 Week Range
0.0011 - 0.0900 - Volume
225 - Avg. Volume
111 - Market Cap (intraday)
13.141M - Beta (5Y Monthly) 1.60
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Sep 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Advanced Health Intelligence Ltd. operates as a mobile application and technology development company in Australia and internationally. It offers biometric health assessments, a multi-step process that employs facial scanning, heart rate measurements, body composition analysis, and cardiovascular fitness tests that evaluates an individual's health. The company also provides FaceScan, process that estimates on heart rate, respiration rate, blood pressure, and other through facial scans; BodyScan, a smart body composition and dimensioning technology that enables user to check and assess body dimensions using a smartphone; and DermaScan, a dermatological scanner. It serves mobile health and telehealth, life and health insurance, wellness, and government sectors. The company was formerly known as Advanced Human Imaging Limited and changed its name to Advanced Health Intelligence Ltd. in December 2022. Advanced Health Intelligence Ltd. was incorporated in 2014 and is based in South Perth, Australia.
www.ahi.techRecent News: MYZQF
View MorePerformance Overview: MYZQF
Trailing total returns as of 11/1/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MYZQF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MYZQF
View MoreValuation Measures
Market Cap
1.08M
Enterprise Value
3.18M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.80
Enterprise Value/Revenue
11.54
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-154.66%
Return on Assets (ttm)
-46.98%
Return on Equity (ttm)
-156.27%
Revenue (ttm)
2.68M
Net Income Avi to Common (ttm)
-4.15M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
25.76k
Total Debt/Equity (mrq)
74.51%
Levered Free Cash Flow (ttm)
48.28k